Author

Tobias Engler

University of TübingenORCID 0000-0002-8063-2053Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Tobias Engler1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

André KochiD· 1 shared André RosaiD· 1 shared Andreas Hartkopf· 1 shared Christian SchmeesiD· 1 shared Eileen Wegner· 1 shared Julia RoosziD· 1 shared Katja Schenke‐LaylandiD· 1 shared Lena Christ· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

André KochORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Ovarian cancer-on-chip for patient-specific profiling of treatment responses to sequential chemotherapy and PD-L1 blockade

Sarah Plöger, Nicole Anderle, Eileen Wegner, Tobias Schmidt, Julia Roosz, Tengku Ibrahim Maulana, Lena Christ, Tobias Engler, Andreas Hartkopf, André Koch, Sara Y. Brucker, Katja Schenke‐Layland, André Rosa, Christian Schmees, Peter Loskill

This paper develops an OvCa-on-chip platform to profile patient-specific treatment responses to chemotherapy and PD-L1 blockade.

bioRxiv · Jul 24, 2026 · PreprintCancer Biology